Literature DB >> 17003846

Analgesic, antiinflammatory, and ulcerogenic studies of meloxicam solid dispersion prepared with polyethylene glycol 6000.

S G Vijaya Kumar1, D N Mishra.   

Abstract

Meloxicam is a nonsteroidal antiinflammatory drug, used in the treatment of rheumatoid arthritis and oestoarthritis. It is practically insoluble in water, leading to poor dissolution, variations in bioavailability, and gastric irritation on oral administration. In the attempt to reduce its gastric side effect and to increase aqueous solubility, physical mixture and solid dispersion of the drug were prepared with polyethylene glycol 6000. The analgesic, antiinflammatory, and ulcerogenic effects were assessed for physical mixture and solid dispersion in comparison with meloxicam alone. The results indicate that both physical mixture and solid dispersion possess better analgesic and antiinflammatory properties with less ulcerogenic potential when compared with pure meloxicam. (c) 2006 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003846     DOI: 10.1358/mf.2006.28.7.1003549

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  3 in total

1.  Synthesis of Diarylpyrazoles Containing a Phenylsulphone or Carbonitrile Moiety and their Chalcones as Possible Anti-Inflammatory Agents.

Authors:  Ekhlass Nassar; Hatem A Abdel-Aziz; Hany S Ibrahim; Ahmed M Mansour
Journal:  Sci Pharm       Date:  2011-07-03

2.  New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5H)ones as Possible Anti-Inflammatory Agents.

Authors:  Christophe Tratrat; Michelyne Haroun; Aliki Paparisva; Charalmpos Kamoutsis; Anthi Petrou; Antonis Gavalas; Phaedra Eleftheriou; Athina Geronikaki; Katharigatta N Venugopala; Hafedh Kochkar; Anroop B Nair
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

3.  Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies.

Authors:  David Izuchukwu Ugwu; Uchechukwu Christopher Okoro; Pius Onyeoziri Ukoha; Astha Gupta; Sunday N Okafor
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.